Sipuleucel-T cellular immunotherapy: Clinical predictors of survival in patients with castration-resistant prostate cancer (CRPC)

Authors :: Lance C. Pagliaro
John C. Araujo
Bradley J. Atkinson
Ana Aparicio
Jeri Kim
Sue-Hwa Lin
Shi-Ming Tu
Christopher J. Logothetis
Padmanee Sharma
Paul G. Corn
Mehmet Asim Bilen
Amado J. Zurita
Nizar M. Tannir
Kenneth R. Hess
Source :: Journal of Clinical Oncology. 32:e16046-e16046
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.
Abstract: e16046 Background: Sipuleucel-T was the first cellular immunotherapy shown to prolong the life of patients with advanced prostate cancer. It was of interest to determine who were those patients mos...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
Castration resistant
medicine.disease
Sipuleucel-T
Prostate cancer
Internal medicine
medicine
In patient
Cellular immunotherapy
business
medicine.drug

Tools